For a comprehensive overview of the microdosing approach, see our GLP-1 microdosing weight management guide
Over the past few years, medicines such as Ozempic, Wegovy, and Mounjaro have become household names in many parts of the world
That framing matters enormously for insurance coverage, for public health budgets, and for whether the people who need them most will ever actually have access to them
Proprionate directly boosts GLP-1 secretion from specific cells in the gut (Singh et al, 2024)
For patients with high coinsurance ($4,000-$6,000 annually), retatrutide costs more than surgery after 3-4 years
Despite the association between obesity and IIH, there have been few prospective studies looking at the precise interaction between weight loss and IIH, leading to a dearth of evidence-based therapeutic guidelines [8]